It is not uncommon for companies to buy and sell
drugs that are in various stages of development,
or to enter into agreements to jointly develop
or market drugs. In these circumstances one
company may receive milestone payments from
another for completing particular stages of
development, trials and approval, as well as
royalties on the drug once it is marketed.
To invest in the right drug to enhance current
portfolio or to supplement current it would be
critical for a pharmaceutical company's
sustained growth in the competitive market.
Molecule screening generally consists of four
steps:
1. Define the market and analyze the market size
and growth rate
2.
Evaluate
the size and growth of target molecule
3.
Further explore the target
molecule, including drivers and barriers,
underlying opportunity and threat, etc.
4.
Forecast the trends in the
coming years.
|